Pages that link to "Q41721460"
Jump to navigation
Jump to search
The following pages link to Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. (Q41721460):
Displaying 50 items.
- Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma (Q24548280) (← links)
- The natural history of EGFR and EGFRvIII in glioblastoma patients (Q24814477) (← links)
- A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy (Q26849503) (← links)
- EGFR Amplification and Glioblastoma Stem-Like Cells (Q26853549) (← links)
- Regulation of brain tumor dispersal by NKCC1 through a novel role in focal adhesion regulation (Q27319526) (← links)
- Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma (Q27326700) (← links)
- Bromelain reversibly inhibits invasive properties of glioma cells (Q28344466) (← links)
- Identifying causal genes and dysregulated pathways in complex diseases (Q28477327) (← links)
- Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177. (Q30437778) (← links)
- Integrin α5β1 facilitates cancer cell invasion through enhanced contractile forces (Q30497917) (← links)
- Four-dimensional analysis of human brain tumor spheroid invasion into fetal rat brain aggregates using confocal scanning laser microscopy (Q32068483) (← links)
- Human enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor (Q33229227) (← links)
- Incorporating molecular tools into early-stage clinical trials (Q33316159) (← links)
- Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme (Q33387317) (← links)
- iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype (Q33493026) (← links)
- The pathobiology of glioma tumors (Q33921072) (← links)
- The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells (Q33957440) (← links)
- Roles of transforming growth factor-alpha and related molecules in the nervous system. (Q34019161) (← links)
- Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer's disease (Q34110934) (← links)
- Gliomagenesis and the use of neural stem cells in brain tumor treatment (Q34310698) (← links)
- Glial ontogeny and glial neoplasia: the search for closure (Q34431307) (← links)
- Biological mechanisms of glioma invasion and potential therapeutic targets (Q34444274) (← links)
- Proliferation and migration of tumor cells in tapered channels (Q34458892) (← links)
- Synergistic antitumor effect between gefitinib and fractionated irradiation in anaplastic oligodendrogliomas cannot be predicted by the Egfr signaling activity. (Q34848038) (← links)
- Polarized regulation of glycogen synthase kinase-3β is important for glioma cell invasion (Q35061356) (← links)
- Association between the epidermal growth factor +61 G/A polymorphism and glioma risk: a meta-analysis (Q35150484) (← links)
- Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors (Q35659088) (← links)
- Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma (Q35800541) (← links)
- HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme (Q36217582) (← links)
- The role of myosin II in glioma invasion: A mathematical model (Q36271552) (← links)
- Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model. (Q36561693) (← links)
- Regulation of cell proliferation and migration in glioblastoma: new therapeutic approach (Q36693243) (← links)
- NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme. (Q36713494) (← links)
- A mechanism for the upregulation of EGF receptor levels in glioblastomas (Q37091283) (← links)
- Combining molecular targeted agents with radiation therapy for malignant gliomas (Q37099594) (← links)
- Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies (Q37141964) (← links)
- The interface between glial progenitors and gliomas (Q37266187) (← links)
- Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain (Q37308322) (← links)
- Multiscale cancer modeling (Q37443767) (← links)
- Passive immunotherapeutic strategies for the treatment of malignant gliomas. (Q37714783) (← links)
- Aberrant signaling pathways in glioma. (Q38161369) (← links)
- HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies. (Q38795844) (← links)
- Potential for modulation of the fas apoptotic pathway by epidermal growth factor in sarcomas (Q38909468) (← links)
- Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ. (Q39121775) (← links)
- EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination? (Q39416297) (← links)
- Gefitinib induces apoptosis in human glioma cells by targeting Bad phosphorylation (Q39509236) (← links)
- Tumorigenesis and prognostic role of hepatoma-derived growth factor in human gliomas (Q39692289) (← links)
- FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin (Q39804071) (← links)
- Multiscale agent-based cancer modeling (Q40048012) (← links)
- Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones (Q40295186) (← links)